Fig. 3From: Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trialProportions of patients who were not in Disease Activity Score based on a 28-joint count (DAS28) remission in the double-blind period. ETN, etanercept; MTX, methotrexateBack to article page